{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:15:47Z","timestamp":1764494147592,"version":"3.40.5"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Mayo Clinic Department of General Internal Medicine"},{"name":"Maurice R. Hilleman Early-Stage Career Investigator Award"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Once an obscure pathogen, Zika virus (ZIKV) has emerged as a significant global public health concern. Several studies have linked ZIKV infection in pregnant women with the development of microcephaly and other neurological abnormalities, emphasizing the need for a safe and effective vaccine to combat the spread of this disease. Preclinical studies and vaccine development efforts have largely focused on the role of humoral immunity in disease protection. Consequently, relatively little is known in regard to cellular immunity against ZIKV, although an effective vaccine will likely need to engage both the humoral and cellular arms of the immune system. To that end, we utilized two-dimensional liquid chromatography coupled with tandem mass spectrometry to identify 90 ZIKV peptides that were naturally processed and presented on HLA class I and II molecules (HLA-A*02:01\/HLA-DRB1*04:01) of an immortalized B cell line infected with ZIKV (strain PRVABC59). Sequence identity clustering was used to filter the number of candidate peptides prior to evaluating memory T cell recall responses in ZIKV convalescent subjects. Peptides that individually elicited broad (4 of 7 subjects) and narrow (1 of 7 subjects) T cell responses were further analyzed using a suite of predictive algorithms and<jats:italic>in silico<\/jats:italic>modeling to evaluate HLA binding and peptide structural properties. A subset of nine broadly reactive peptides was predicted to provide robust global population coverage (97.47% class I; 70.74% class II) and to possess stable structural properties amenable for vaccine formulation, highlighting the potential clinical benefit for including ZIKV T cell epitopes in experimental vaccine formulations.<\/jats:p>","DOI":"10.1371\/journal.pone.0252198","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T22:00:56Z","timestamp":1622671256000},"page":"e0252198","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5767","authenticated-orcid":true,"given":"Stephen N.","family":"Crooke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4457","authenticated-orcid":true,"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"pone.0252198.ref001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"GW Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pone.0252198.ref002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","article-title":"Degrees of maturity: the complex structure and biology of flaviviruses","volume":"2","author":"TC Pierson","year":"2012","journal-title":"Curr Opin Virol"},{"key":"pone.0252198.ref003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.41.20929","article-title":"Concurrent outbreaks of dengue, chikungunya and Zika virus infections\u2014an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012\u20132014","volume":"19","author":"A Roth","year":"2014","journal-title":"Euro Surveill"},{"key":"pone.0252198.ref004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"VM Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"pone.0252198.ref005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/CMR.00014-16","article-title":"Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes","volume":"29","author":"A Panchaud","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"pone.0252198.ref006","article-title":"Zika and the Risk of Microcephaly","author":"MA Johansson","year":"2016","journal-title":"New Engl J Med"},{"key":"pone.0252198.ref007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5858\/arpa.2016-0382-RA","article-title":"Zika Virus Infection in Pregnancy, Microcephaly, and Maternal and Fetal Health: What We Think, What We Know, and What We Think We Know","volume":"141","author":"MG Alvarado","year":"2017","journal-title":"Arch Pathol & Lab Med"},{"key":"pone.0252198.ref008","first-page":"19","article-title":"Zika infection and the development of neurological defects","author":"FB Russo","year":"2017","journal-title":"Cell Microbiol"},{"key":"pone.0252198.ref009","article-title":"The reemergence of Zika virus: a review on pathogenesis, clinical manifestations, diagnosis, and treatment","author":"W Shuaib","year":"2016","journal-title":"Am J Med"},{"key":"pone.0252198.ref010","unstructured":"World Health Organization WH. Guillain-Barr\u00e9 syndrome\u2013Brazil. https:\/\/www.who.int\/csr\/don\/8-february-2016-gbs-brazil\/en\/. 2016."},{"key":"pone.0252198.ref011","doi-asserted-by":"crossref","DOI":"10.3201\/eid2304.161692","article-title":"Presence and Persistence of Zika Virus RNA in Semen, United Kingdom, 2016","volume":"23","author":"B Atkinson","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"pone.0252198.ref012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(16)00138-9","article-title":"Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?","volume":"16","author":"JM Mansuy","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"pone.0252198.ref013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(16)00080-5","article-title":"Anticipating the international spread of Zika virus from Brazil","volume":"387","author":"II Bogoch","year":"2016","journal-title":"Lancet"},{"key":"pone.0252198.ref014","first-page":"215","article-title":"Transmission of Zika Virus Through Sexual Contact with Travelers to Areas of Ongoing Transmission\u2014Continental United States, 2016","volume":"65","author":"SL Hills","year":"2016","journal-title":"MMWR"},{"key":"pone.0252198.ref015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/uog.15831","article-title":"Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?","volume":"47","author":"AS Oliveira Melo","year":"2016","journal-title":"Ultrasound Obstetr & Gynecol"},{"key":"pone.0252198.ref016","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(19)32790-4","article-title":"The first local cases of Zika virus in Europe","volume":"394","author":"OJ Brady","year":"2019","journal-title":"Lancet"},{"key":"pone.0252198.ref017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PHH.0000000000000990","article-title":"Local Transmission of Zika Virus in Miami-Dade County: The Florida Department of Health Rises to the Challenge","volume":"25","author":"C Philip","year":"2019","journal-title":"J Public Health Management Practice"},{"key":"pone.0252198.ref018","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41590-020-0648-y","article-title":"Climate change: an enduring challenge for vector-borne disease prevention and control","volume":"21","author":"J Rocklov","year":"2020","journal-title":"Nat Immunol"},{"key":"pone.0252198.ref019","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.mayocp.2019.05.016","article-title":"Zika Vaccine Development: Current Status","volume":"94","author":"GA Poland","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"pone.0252198.ref020","article-title":"Development of vaccines against Zika virus","author":"GA Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pone.0252198.ref021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"MR Gaudinski","year":"2018","journal-title":"The Lancet"},{"key":"pone.0252198.ref022","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"P Abbink","year":"2016","journal-title":"Science"},{"key":"pone.0252198.ref023","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"G Sapparapu","year":"2016","journal-title":"Nature"},{"key":"pone.0252198.ref024","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"RA Larocca","year":"2016","journal-title":"Nature"},{"key":"pone.0252198.ref025","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"B Shrestha","year":"2004","journal-title":"J Virol"},{"key":"pone.0252198.ref026","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"LE Yauch","year":"2009","journal-title":"J Immunol"},{"key":"pone.0252198.ref027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice","volume":"21","author":"A Elong Ngono","year":"2017","journal-title":"Cell Host & Microbe"},{"key":"pone.0252198.ref028","doi-asserted-by":"crossref","first-page":"e1007237","DOI":"10.1371\/journal.ppat.1007237","article-title":"CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection","volume":"14","author":"M Hassert","year":"2018","journal-title":"PLoS Pathog"},{"key":"pone.0252198.ref029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vaccine.2009.09.126","article-title":"Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development","volume":"28","author":"KL Johnson","year":"2009","journal-title":"Vaccine"},{"key":"pone.0252198.ref030","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/pr0501416","article-title":"Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry","volume":"4","author":"KL Johnson","year":"2005","journal-title":"J Proteome Resh"},{"key":"pone.0252198.ref031","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jasms.2005.07.015","article-title":"Accurate mass precursor ion data and tandem mass spectrometry identify a class I Human Leukocyte Antigen A*0201-presented peptide originating from vaccinia virus","volume":"16","author":"KL Johnson","year":"2005","journal-title":"J Amer Soc Mass Spectrometry"},{"key":"pone.0252198.ref032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.78.1.42-51.2004","article-title":"Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides","volume":"78","author":"IG Ovsyannikova","year":"2004","journal-title":"J Virol"},{"key":"pone.0252198.ref033","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0042-6822(03)00281-2","article-title":"Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood","volume":"312","author":"IG Ovsyannikova","year":"2003","journal-title":"Virol"},{"key":"pone.0252198.ref034","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002371-199308000-00003","article-title":"Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution","volume":"14","author":"WJ Storkus","year":"1993","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"pone.0252198.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"I Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"pone.0252198.ref036","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"M Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"pone.0252198.ref037","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"KK Jensen","year":"2018","journal-title":"Immunol"},{"key":"pone.0252198.ref038","doi-asserted-by":"crossref","first-page":"e1000048","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"P Wang","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"pone.0252198.ref039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"M Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"pone.0252198.ref040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"M Nielsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"pone.0252198.ref041","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"T Sturniolo","year":"1999","journal-title":"Nat Biotechnol"},{"key":"pone.0252198.ref042","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"J Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"pone.0252198.ref043","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jmb.2004.04.005","article-title":"A hidden markov model derived structural alphabet for proteins","volume":"339","author":"AC Camproux","year":"2004","journal-title":"J Molec Biol"},{"key":"pone.0252198.ref044","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jcc.21365","article-title":"A fast method for large-scale de novo peptide and miniprotein structure prediction","volume":"31","author":"J Maupetit","year":"2010","journal-title":"J Comput Chem"},{"key":"pone.0252198.ref045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/prot.21505","article-title":"A coarse-grained protein force field for folding and structure prediction","volume":"69","author":"J Maupetit","year":"2007","journal-title":"Proteins"},{"key":"pone.0252198.ref046","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/092986607781483859","article-title":"PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides","volume":"14","author":"H Kaur","year":"2007","journal-title":"Protein Peptide Letters"},{"key":"pone.0252198.ref047","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/psc.1410","article-title":"In silico predictions of 3D structures of linear and cyclic peptides with natural and non-proteinogenic residues","volume":"18","author":"J Beaufays","year":"2012","journal-title":"J Peptide Sci"},{"key":"pone.0252198.ref048","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"MR Wilkins","year":"1999","journal-title":"Methods Mol Biol"},{"key":"pone.0252198.ref049","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"HH Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"pone.0252198.ref050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.3018930","article-title":"In vivo half-life of a protein is a function of its amino-terminal residue","volume":"234","author":"A Bachmair","year":"1986","journal-title":"Science"},{"key":"pone.0252198.ref051","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0020-7519(03)00062-6","article-title":"Experimental vaccines against measles in a world of changing epidemiology","volume":"33","author":"MM Putz","year":"2003","journal-title":"Int J Parasitol"},{"key":"pone.0252198.ref052","first-page":"1895","article-title":"Thermostability and aliphatic index of globular proteins","volume":"88","author":"A Ikai","year":"1980","journal-title":"J Biochem"},{"key":"pone.0252198.ref053","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.it.2017.05.004","article-title":"T Cell Immunity and Zika Virus Vaccine Development","volume":"38","author":"NS Lima","year":"2017","journal-title":"Trends Immunol"},{"key":"pone.0252198.ref054","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02861-18","article-title":"Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus","volume":"10","author":"MJ Bailey","year":"2019","journal-title":"mBio"},{"key":"pone.0252198.ref055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2388","article-title":"NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice","volume":"5","author":"B Grubor-Bauk","year":"2019","journal-title":"Sci Advances"},{"key":"pone.0252198.ref056","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model","volume":"9","author":"MJ Bailey","year":"2018","journal-title":"Nat Commun"},{"key":"pone.0252198.ref057","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48460","article-title":"Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji","volume":"9","author":"AD Henderson","year":"2020","journal-title":"eLife"},{"key":"pone.0252198.ref058","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"S Scheiblhofer","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"pone.0252198.ref059","doi-asserted-by":"crossref","first-page":"e1000231","DOI":"10.1371\/journal.pcbi.1000231","article-title":"Structural and thermodynamic approach to peptide immunogenicity","volume":"4","author":"CJ Camacho","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"pone.0252198.ref060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","article-title":"A large peptidome dataset improves HLA class I epitope prediction across most of the human population","volume":"38","author":"S Sarkizova","year":"2020","journal-title":"Nat Biotechnol"},{"key":"pone.0252198.ref061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41571-019-0315-0","article-title":"Improved MHC II epitope prediction\u2014a step towards personalized medicine","volume":"17","author":"TV Moore","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0252198.ref062","first-page":"644","article-title":"Mass spectrometry and peptide-based vaccine development","volume":"82","author":"IG Ovsyannikova","year":"2007","journal-title":"Clin PharmacolTher"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:39:19Z","timestamp":1699101559000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252198"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252198","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,6,2]]}}}